Moreno, Christof T.

HRN: 18-61-42  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/27/2024
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
10/27/2024
11/06/2024
PO
200 Mg / 8ml
Q 8 Hours
Intestinal Amoebiasis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Non-compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: